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Extracellular matrix molecules, including collagen, glycosaminoglycans (usually linked to a
protein core as proteoglycan), elastin, and glycoproteins, influence the initiation and maintenance
ofdifferentiation ofa variety ofcell types. These molecules bind to the cell surface at specific sites
and nonspecifically by electrostatic forces. Such interactions may alter the cell's response to
growth and differentiation factors. After neoplastic transformation, most cells retain some
dependence on these factors. This paper reviews the influence of matrix components on the
phenotype of a variety of malignant cells and concludes that in vitro studies of malignant cell
behavior require the utilization ofan appropriate microenvironment.
The microenvironment of a cell is essential to the differentiation process. A major
factor in the influence ofthe microenvironment is the continuing interaction ofthe cell
surface with the extracellular matrix [1]. The basic structural composition of the
matrix consists of at least four major classes of macromolecules, including collagen,
glycosaminoglycans (usually linked to a protein core as proteoglycan), elastin, and
glycoproteins, including laminin and fibronectin [1]. These molecules influence the
initiation and maintenance of differentiation of a variety of cell types, including
myoblasts [2,3], corneal endothelial cells [4], kidney epithelial cells [5], and hepato-
cytes [6]. Neural crest cells may express the mature phenotype or a melanocyte or a
catecholamine-containing cell, depending on their environment [7].
It has been suggested that substrata can modify cell shape and orientation and allow
cells to respond to naturally occurring hormones and growth factors to which they do
not respond when maintained on other substrata [8]. For example, Gospodarowicz et
al. [9] found that corneal epithelial cells adopt a flattened configuration when
maintained in vitro on plastic and arevery sensitive to fibroblast growth factor, but not
to epidermal growth factor. When maintained on collagen, these cells become
columnar with enhanced responsiveness to epidermal growth factor. Changes in cell
shape have previously been associated with changes in DNA [10], RNA, and protein
synthesis [11]. It has been suggested that the cell cytoskeleton may affect protein
synthesis by dictating the arrangement of the polyribosomes associated with the
microtrabeculae [12].
The cell-surface-extracellular matrix is believed to be a continuum without demar-
cation [13]. Matrix molecules bind to the cell at specific sites and nonspecifically by
electrostatic forces [13]. In addition, matrix molecules have binding sites for other
matrix components [14,15]. It has also been demonstrated that membrane-interca-
lated heparan sulfate interacts with polymerized actin [16].
Although the shape of transformed cells is not closely correlated with growth [10],
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TABLE 1
Matrix-Induced Changes in Malignant Cell Phenotype
Cell Substrata Parameters References
1003 embryonal carcinoma Laminin Growth, morphology, neurite ex- [18]
tension, muscular differentia-
tion
MKN-28 gastric carci- Fixed fibroblasts Morphology, glycosaminoglycans [19]
noma
Hepatoma Collagen Growth, morphology, tyrosine [20]
aminotransferase
B16 melanoma Collagen I, IV Morphology, glycosaminoglycans [21]
Laminin Growth, pigmentation [22]
MCF-7 mammary carci- Collagen Morphology [23]
noma
Acute myeloid leukemia Marrow adherent cells Growth, B4.3, myeloperoxidase [24]
PC-12 pheochromocytoma Collagen I or colon Morphology, growth, neurite ex- [25]
cancer matrix tension
HL-60 leukemia Marrow matrix Growth, morphology, esterase [26]
U-343 glioma Collagen I, IV or pia- Growth, morphology [27]
arachnoid
BSp73-AS pancreatic can- Endothelial matrix Morphology [28]
cer
neoplastic cells retain some dependence on the growth and differentiation factors of
their environment. For example, the malignant behavior ofembryonal carcinoma cells
can be reversed under appropriate environmental conditions [17]. As shown in Table 1,
a variety of malignant cells in vitro express phenotypic changes in response to
substrata.
We have previously demonstrated the influence of the extracellular matrix on
neoplastic cell behavior [21]. Thus, we have shown that B16 melanoma cells display
altered morphology when grown on collagen I or IV substrata compared to cultures on
plastic. On type IV collagen only, cells demonstrated an increased substrate adhesive-
ness. Incorporation of [3H]-glucosamine and [35S]-sulfate into glycosaminoglycans of
cells grown on collagen substrata was 20 percent and 40 percent less, respectively, than
cells grown on plastic. Although the composition ofglycosaminoglycans was similar in
all cultures, consisting ofapproximately 60 percentchondroitin and 40 percent heparin
or heparan sulfate, the degree ofsulfation ofthe heparin or heparan sulfate molecules
was markedly decreased in cultures grown on collagen. Our results indicated that the
composition of the extracellular matrix influenced the biological behavior of B16
melanoma cells, in part by altering the amount and nature of the glycosaminoglycan
molecules produced. Similarly, endothelial cell-derived matrix has recently been
demonstrated to alter proteoglycan surface antigen expression by human melanoma
cells [29].
The role of the bone marrow microenvironment in the regulation of normal and
malignant hematopoietic cell development is another example of cell-matrix interac-
tion. The specificity of organ sites in which hematopoiesis occurs is demonstrated by
the homing of transfused marrow cells to recipient mouse marrow and spleen [30].
Cells that go to the spleen form predominantly erythroid colonies and those in marrow
form granulocyte colonies [31]. The need for a supportive environment was also
demonstrated in the genetically anemicS1/Sld mouse strain [32]. Their anemia is not
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reversed by normal hematopoietic cells, but is cured by normal spleen [33] or marrow
stroma [34].
In vitro studies also confirm the requirement for a supportive stroma [35].
Endothelial cells, fibroblasts, reticular-like cells, adipocytes, and macrophages from
bone marrow form a layer which is adherent to the tissue culture flask and supports
development of hematopoietic cells. In this environment, pluripotent stem cells can
proliferate and differentiate to a variety of blood cell types, and such bone marrow
cultures can be maintainted for several months. Non-marrow stroma is unable to
support the hematopoietic process [36].
The stroma also appears to maintain control over neoplastic hematopoietic cells. In
vitro studies demonstrated that freshly isolated myeloblasts express mature leukocyte
surface antigens without morphologic maturation when grown in co-culture with
adherent cells from normal marrow [24]. To investigate further the influence of bone
marrow stroma on leukemic cell phenotype, HL-60 human promyelocytic leukemia
cells were grown in the presence of extracellular matrix derived from normal human
bone marrow stroma cells [26]. After six days in culture, cell number decreased by 54
percent in matrix-coated compared to uncoated flasks. Morphologic changes of the
HL-60 cells on matrix included vacuolization, spreading of the cytoplasmic borders,
and decreased ratio of nucleus to cytoplasm. These cells also developed nonspecific
esterase activity and induced Fc rosette formation. Additionally, bone marrow matrix
altered the response of HL-60 cells to differentiation inducers. For example, cells
grown on matrix mature in the presence of 1 nM 12-O-tetradecanoylphorbol-
13-acetate (TPA), a concentration that does not induce differentiation of cells in
uncoated plastic flasks [37].
Since tumor cell-matrix interactions do influence cell phenotype and response to
proliferative and differentiation factors, future in vitro studies of malignancy may
require the utilization ofadequate matrices for stabilization ofphenotype and for more
accurate prediction of in vivo therapeutic response.
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